United States · FDA National Drug Code directory
Rizatriptan Benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-085_e693bf18-c909-41c8-bfd5-21cb4458b925
- Product NDC
- 57237-085
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Rizatriptan Benzoate
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130701
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (57237-085-63) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 57237-085-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →